Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Aurobindo Pharma Ltd.
NSE: AUROPHARMA
|
BSE: 524804
|
ISIN: INE406A01037
|
Industry: Pharmaceuticals
Proposed Buyback
Board Meeting
|
Turnaround Potential
1333.7000
-8.40
(
-0.63
%)
NSE
Apr 02, 2026
15:31 PM
New 52W High in past week
Volume:
1.9M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Aurobindo Pharma Ltd.
11 Feb 2026
Proposed Buyback
Board Meeting
1333.70
-0.63%
Result Update:Aurobindo Pharma
Buy:
Aurobindo Pharma Ltd.
by
Axis Direct
Target: 1345 | Target met
Axis Direct
We maintain our BUY recommendation on the stock with a TP of Rs 1,345/share.
Aurobindo Pharma Ltd. is trading above all available SMAs
More from Aurobindo Pharma Ltd.
Recommended
Five Interesting Stocks Today - April 2, 2026
The Baseline |
02 Apr 2026
Market closes higher on strong rupee and value buying
Trendlyne Marketwatch |
02 Apr 2026
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
|
15 Jul 2020